CTSB and hepatocellular carcinoma: Clinically, we show that high CTSB expression associates with increased incidence of BDTT in HCC patients, while the HCC patients with BDTT have an elevated serum CTSB level, suggesting that CTSB could potentially function as a diagnostic marker and therapeutic target for HCC patients with BDTT and warrants further investigation.